Clinical Trial Update: Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SIBP's Measles-Mumps-Rubella vaccine with GlaxoSmithKline's MMR vaccine in children aged 9-11 months has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella

Drugs mentioned

• Priorix (Measles-Mumps-Rubella Vaccine)
• SIBP MMR Vaccine (Measles-Mumps-Rubella Vaccine)

Snippet

Sponsor: Shanghai Institute Of Biological Products | Conditions: Measles-Mumps-Rubella | Phase 3 | Status: COMPLETED